Semaglutide Drugs
-
{
- All
- News
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
Ozempic, Fitness Apps, Olive Oil: Inside India's $170 Billion Wellness Rush
The modern urban consumer is not just trying to get healthier. They are trying to measure health. Health is becoming part of personal identity.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Ozempic And Wegovy Weight Loss Eventually Plateaus, Study Explains Why
While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Weight Loss Drugs May Be Making Patients Lose More Than Just Fat
UNC researchers found popular incretin drugs like semaglutide and tirzepatide are linked to unusually high muscle loss during weight loss.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
Ozempic, Fitness Apps, Olive Oil: Inside India's $170 Billion Wellness Rush
The modern urban consumer is not just trying to get healthier. They are trying to measure health. Health is becoming part of personal identity.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Ozempic And Wegovy Weight Loss Eventually Plateaus, Study Explains Why
While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Weight Loss Drugs May Be Making Patients Lose More Than Just Fat
UNC researchers found popular incretin drugs like semaglutide and tirzepatide are linked to unusually high muscle loss during weight loss.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
